Marzo 31, 2022 Iama Therapeutics Raises €8 Million Series A IAMA THERAPEUTICS RACCOGLIE 8 MILIONI […] Iama therapeutics raises €8 Million Series A
Marzo 24, 2022 Heqet Therapeutics raises €8m to advance its RNA-based therapeutic program for cardiac […] Hequet Therapeutics raises €8 million
Marzo 24, 2022 Kither Biotech Raises €18.5 Million Series B Kither Biotech Raises €18.5 Million […] Kither Biotech Raises €18.5 Million Series B
Luglio 21, 2021 Claris Ventures announces final closing: €85m ($100m) for Italian Biotech Fund oversubscription, […] Claris Biotech I Final Closing
Marzo 9, 2021 NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline Round led […] NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline
Settembre 1, 2020 Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso […] CLARIS VENTURES LANCIA UN FONDO DEDICATO AL BIOTECH ITALIANO
Aprile 7, 2020 La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma […] Claris Ventures sulla rivista Prisma di Aprile
Aprile 7, 2020 Covid-19: new report from Claris Ventures on development of drugs and vaccines […] COVID-19: Claris Ventures publishes its report on vaccines and drugs in development
Aprile 7, 2020 Business Insider: Claris, il primo fondo di venture capital italiano che investe […] Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore
Febbraio 14, 2020 Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi […] VentureUp Forum 2020
Novembre 16, 2019 Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di […] Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)
Luglio 5, 2019 Kither Biotech raises a €5.6m financing round to support the clinical development […] Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases
Maggio 20, 2019 Claris Ventures guest speaker at “The drug from basic research to therapy” […] Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology
